Xiaoshuang Chen, MD
Family Practice · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 11 years
- Graduated 2015
Offices
2 locations · Asian Health Services · 93 clinicians in this group
Looking this up.
Hospitals listed: 557747 · 557754 · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Eden Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A156687 · Current
Licensed to practise in California · since 2018 · expires 2027-09-30 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$373
Medicare paid this office $373 for 25 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $268 | $11 |
Who their Medicare patients are
25 Original Medicare patients in 2024. Average age 77 · Under 65 0% · Also on Medicaid 100% · Health risk score 1.02. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 64%.
The office billed $3,415, Medicare allowed $685 and paid $373; for 26 services of 2 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 25 | 26 | 77 | 1.02 | $3,415 | $373 |
| 2023 | 19 | 19 | 77 | 1.12 | $1,767 | $181 |
| 2022 | 27 | 28 | 76 | 0.84 | $2,604 | $177 |
| 2021 | 37 | 42 | 74 | 1.07 | $3,475 | $428 |
| 2020 | 16 | 18 | 76 | 1.26 | $1,178 | $345 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $181 | $10 |
2022: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $177 | $6 |
2021: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 34 | $228 | $7 |
Medicaid work
$621,514 in 2024
Medicaid paid $621,514 for 7,797 billed services this clinician did in 2024, up to 248 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 2,534 | $616,905 |
| Return visit (30+ min) | 1,367 | $1,969 |
| Short return visit (20+ min) | 1,627 | $1,344 |
| Long return visit (40+ min) | 595 | $1,262 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 161 | $29 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 144 | $5 |
| Hemoglobin A1C level | 637 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 14 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 543 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 70 | $0 |
| Administration of influenza virus vaccine | 53 | $0 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 24 | $0 |
| 2024 | 7,797 | 13 | 248 | $621,514 |
| 2023 | 7,395 | 15 | 238 | $597,489 |
| 2022 | 6,540 | 13 | 204 | $414,491 |
| 2021 | 6,239 | 8 | 188 | $500,763 |
| 2020 | 6,472 | 8 | 192 | $487,188 |
| 2019 | 4,790 | 10 | 204 | $368,987 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 2,535 | $595,429 |
| Short return visit (20+ min) | 2,057 | $1,170 |
| Return visit (30+ min) | 1,525 | $844 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 15 | $46 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose | 31 | $0 |
| Hemoglobin A1C level | 422 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 77 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 91 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 14 | $0 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use | 31 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 405 | $0 |
| Long return visit (40+ min) | 38 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,785 | $414,277 |
| Short return visit (20+ min) | 1,880 | $120 |
| Return visit (30+ min) | 1,658 | $94 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose | 22 | $0 |
| Hemoglobin A1C level | 428 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 15 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 256 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 103 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 51 | $0 |
| PPSV23 VACC 2 YRS+ SUBQ/IM | 12 | $0 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use | 22 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 296 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 2,210 | $499,116 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose | 20 | $1,340 |
| Return visit (30+ min) | 1,622 | $188 |
| Short return visit (20+ min) | 2,159 | $120 |
| Hemoglobin A1C level | 54 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 76 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 78 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 20 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 2,252 | $486,715 |
| Short return visit (20+ min) | 2,626 | $333 |
| Return visit (30+ min) | 1,308 | $141 |
| Hemoglobin A1C level | 53 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 130 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 28 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 39 | $0 |
| Short return visit | 36 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,654 | $368,542 |
| Return visit (30+ min) | 812 | $234 |
| Short return visit (20+ min) | 1,471 | $210 |
| Hemoglobin A1C level | 291 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 257 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 214 | $0 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 15 | $0 |
| MEASURE BLOOD OXYGEN LEVEL | 12 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 26 | $0 |
| Administration of influenza virus vaccine | 38 | $0 |
Drugs they prescribed that Part D paid
$709,309
Pharmacies billed $709,309 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
4,322 generic and 694 brand-name prescriptions · $709,309 in drug cost · 55 antibiotic prescriptions to 40 people · 19 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rybelsus | 97 | $182,560 | $1,882 |
| Jardiance | 61 | $91,693 | $1,503 |
| Ozempic | 61 | $71,885 | $1,178 |
| Januvia | 36 | $48,758 | $1,354 |
| Eliquis | 25 | $37,502 | $1,500 |
See all 77 drugs
| Rybelsus | 97 | $182,560 | $1,882 |
| Jardiance | 61 | $91,693 | $1,503 |
| Ozempic | 61 | $71,885 | $1,178 |
| Januvia | 36 | $48,758 | $1,354 |
| Eliquis | 25 | $37,502 | $1,500 |
| Prolia | 13 | $21,421 | $1,648 |
| Vemlidy | 15 | $20,525 | $1,368 |
| Tradjenta | 15 | $17,874 | $1,192 |
| Breo Ellipta | 23 | $13,471 | $586 |
| Basaglar Kwikpen U-100 | 34 | $10,617 | $312 |
| Incruse Ellipta | 12 | $10,268 | $856 |
| Fiasp Flextouch | 14 | $8,300 | $593 |
| Entecavir | 21 | $6,785 | $323 |
| Arnuity Ellipta | 14 | $4,574 | $327 |
| Tudorza Pressair | 13 | $3,978 | $306 |
| Advair Hfa | 11 | $3,939 | $358 |
| Atorvastatin | 517 | $3,711 | $7 |
| Albuterol Sulfate Hfa | 85 | $2,933 | $35 |
| Colchicine | 30 | $2,570 | $86 |
| Losartan | 307 | $2,022 | $7 |
| Diclofenac | 59 | $1,749 | $30 |
| Famotidine | 157 | $1,655 | $11 |
| Alendronate | 235 | $1,617 | $7 |
| Amlodipine Besylate | 396 | $1,605 | $4 |
| Metformin | 253 | $1,474 | $6 |
| Tamsulosin | 85 | $1,363 | $16 |
| Metoprolol | 98 | $1,212 | $12 |
| Pantoprazole | 85 | $1,043 | $12 |
| Pregabalin | 16 | $1,043 | $65 |
| Fluticasone Propionate | 127 | $902 | $7 |
| Gabapentin | 41 | $744 | $18 |
| Lisinopril | 146 | $726 | $5 |
| Meclizine | 68 | $725 | $11 |
| Ventolin Hfa | 13 | $719 | $55 |
| Nifedipine Er | 12 | $679 | $57 |
| Fluocinonide | 31 | $676 | $22 |
| Levothyroxine | 62 | $649 | $10 |
| Ciclopirox | 21 | $647 | $31 |
| Mirtazapine | 21 | $547 | $26 |
| Donepezil | 41 | $506 | $12 |
| Clobetasol Propionate | 14 | $473 | $34 |
| Finasteride | 40 | $439 | $11 |
| Allopurinol | 47 | $423 | $9 |
| Proctozone-Hc | 16 | $423 | $26 |
| Omeprazole | 45 | $422 | $9 |
| Hydrocortisone | 46 | $409 | $9 |
| Doxazosin Mesylate | 19 | $404 | $21 |
| Glipizide | 39 | $388 | $10 |
| Baclofen | 25 | $373 | $15 |
| Escitalopram | 55 | $369 | $7 |
| Hydralazine | 15 | $365 | $24 |
| Simvastatin | 60 | $300 | $5 |
| Metformin Hcl Er | 17 | $288 | $17 |
| Trazodone | 48 | $279 | $6 |
| Rosuvastatin | 28 | $259 | $9 |
| Azelastine | 25 | $252 | $10 |
| Hydrochlorothiazide | 132 | $231 | $2 |
| Triamcinolone Acetonide | 55 | $229 | $4 |
| Isosorbide Mononitrate Er | 15 | $220 | $15 |
| Atenolol | 18 | $193 | $11 |
| Naproxen | 22 | $181 | $8 |
| Metoprolol | 40 | $156 | $4 |
| Carvedilol | 31 | $151 | $5 |
| Citalopram Hbr | 18 | $145 | $8 |
| Montelukast | 15 | $144 | $10 |
| Clopidogrel | 24 | $131 | $5 |
| Pravastatin | 11 | $113 | $10 |
| Amoxicillin-Clavulanate Potass | 13 | $86 | $7 |
| Benazepril | 13 | $78 | $6 |
| Triamterene-Hydrochlorothiazid | 11 | $72 | $7 |
| Sertraline | 16 | $53 | $3 |
| Meloxicam | 16 | $52 | $3 |
| Furosemide | 31 | $40 | $1 |
| Quetiapine | 17 | $33 | $2 |
| Clonazepam | 11 | $26 | $2 |
| Sulfamethoxazole-Trimethoprim | 17 | $14 | $1 |
| Paxlovid | 16 | $0 | $0 |
Year by year
| 2024 | 5,057 | 552 | None | 14% | $709,309 |
| 2023 | 5,052 | 507 | None | 11% | $701,270 |
| 2022 | 4,933 | 511 | None | 11% | $530,064 |
| 2021 | 4,581 | 421 | None | 10% | $380,606 |
| 2020 | 4,231 | 486 | None | 10% | $348,047 |
| 2019 | 1,452 | 418 | None | None | $89,038 |
| 2018 | 603 | 92 | 4% (26) | None | $47,042 |
| 2017 | 877 | 136 | 8% (72) | None | $48,801 |
| 2016 | 300 | 61 | 11% (32) | 9% | $8,047 |
| 2015 | 12 | None | 0% (0) | None | $1,664 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 70 drugs
| Jardiance | 43 | $71,831 | $1,670 |
| Januvia | 41 | $65,600 | $1,600 |
| Rybelsus | 29 | $62,834 | $2,167 |
| Tradjenta | 27 | $32,344 | $1,198 |
| Atorvastatin | 549 | $21,028 | $38 |
| Advair Diskus | 38 | $20,921 | $551 |
| Eliquis | 18 | $18,522 | $1,029 |
| Vemlidy | 11 | $17,039 | $1,549 |
| Incruse Ellipta | 15 | $14,451 | $963 |
| Amlodipine Besylate | 422 | $13,083 | $31 |
| Losartan | 315 | $12,582 | $40 |
| Trulicity | 12 | $11,735 | $978 |
| Basaglar Kwikpen U-100 | 29 | $9,724 | $335 |
| Alendronate | 228 | $7,384 | $32 |
| Diclofenac | 228 | $7,178 | $31 |
| Metformin | 229 | $6,730 | $29 |
| Famotidine | 125 | $5,391 | $43 |
| Breo Ellipta | 12 | $5,197 | $433 |
| Lisinopril | 162 | $5,159 | $32 |
| Symbicort | 11 | $4,845 | $440 |
| Entecavir | 17 | $4,446 | $262 |
| Shingrix | 19 | $4,199 | $221 |
| Flovent Hfa | 13 | $4,168 | $321 |
| Metoprolol | 105 | $3,539 | $34 |
| Ventolin Hfa | 55 | $3,413 | $62 |
| Albuterol Sulfate Hfa | 64 | $3,291 | $51 |
| Tamsulosin | 80 | $3,087 | $39 |
| Pantoprazole | 73 | $2,914 | $40 |
| Gabapentin | 39 | $2,554 | $65 |
| Fluticasone Propionate | 118 | $2,541 | $22 |
| Trazodone | 72 | $2,342 | $33 |
| Escitalopram | 38 | $2,211 | $58 |
| Simvastatin | 70 | $2,110 | $30 |
| Levothyroxine | 64 | $2,030 | $32 |
| Fluocinonide | 28 | $2,017 | $72 |
| Colchicine | 12 | $1,925 | $160 |
| Nifedipine Er | 23 | $1,896 | $82 |
| Mirtazapine | 47 | $1,815 | $39 |
| Glipizide | 55 | $1,682 | $31 |
| Hydrochlorothiazide | 155 | $1,656 | $11 |
| Hydrocortisone | 61 | $1,475 | $24 |
| Doxazosin Mesylate | 23 | $1,454 | $63 |
| Allopurinol | 35 | $1,326 | $38 |
| Carvedilol | 37 | $1,290 | $35 |
| Omeprazole | 42 | $1,264 | $30 |
| Metoprolol | 51 | $1,191 | $23 |
| Pravastatin | 35 | $1,176 | $34 |
| Ciclopirox | 14 | $1,174 | $84 |
| Donepezil | 21 | $1,131 | $54 |
| Citalopram Hbr | 24 | $1,100 | $46 |
| Sertraline | 25 | $1,076 | $43 |
| Baclofen | 18 | $1,040 | $58 |
| Finasteride | 32 | $1,002 | $31 |
| Montelukast | 26 | $846 | $33 |
| Clopidogrel | 20 | $755 | $38 |
| Azelastine | 24 | $716 | $30 |
| Metformin Hcl Er | 22 | $675 | $31 |
| Rosuvastatin | 19 | $654 | $34 |
| Benazepril | 26 | $630 | $24 |
| Naproxen | 23 | $581 | $25 |
| Meclizine | 26 | $573 | $22 |
| Hydralazine | 16 | $555 | $35 |
| Atenolol | 19 | $517 | $27 |
| Proctozone-Hc | 11 | $334 | $30 |
| Triamcinolone Acetonide | 31 | $274 | $9 |
| Furosemide | 26 | $249 | $10 |
| Paxlovid (Eua) | 17 | $177 | $10 |
| Mupirocin | 12 | $141 | $12 |
| Prednisone | 18 | $92 | $5 |
| Sulfamethoxazole-Trimethoprim | 14 | $74 | $5 |
2022: 74 drugs
| Januvia | 56 | $85,391 | $1,525 |
| Jardiance | 21 | $33,339 | $1,588 |
| Tradjenta | 27 | $31,977 | $1,184 |
| Trulicity | 15 | $21,613 | $1,441 |
| Spiriva Handihaler | 13 | $16,508 | $1,270 |
| Eliquis | 15 | $13,079 | $872 |
| Advair Diskus | 18 | $13,006 | $723 |
| Atorvastatin | 521 | $9,707 | $19 |
| Lantus Solostar | 24 | $9,323 | $388 |
| Shingrix | 41 | $8,268 | $202 |
| Symbicort | 20 | $7,833 | $392 |
| Amlodipine Besylate | 418 | $5,649 | $14 |
| Diclofenac | 156 | $5,595 | $36 |
| Breo Ellipta | 13 | $5,369 | $413 |
| Losartan | 294 | $5,313 | $18 |
| Flovent Hfa | 11 | $4,197 | $382 |
| Colchicine | 19 | $4,016 | $211 |
| Famotidine | 160 | $3,920 | $25 |
| Albuterol Sulfate Hfa | 83 | $3,917 | $47 |
| Alendronate | 209 | $3,753 | $18 |
| Metformin | 232 | $3,407 | $15 |
| Metoprolol | 120 | $2,746 | $23 |
| Entecavir | 12 | $2,560 | $213 |
| Nifedipine Er | 23 | $2,296 | $100 |
| Lisinopril | 171 | $2,252 | $13 |
| Tamsulosin | 86 | $1,889 | $22 |
| Fluocinonide | 36 | $1,843 | $51 |
| Levothyroxine | 75 | $1,785 | $24 |
| Ventolin Hfa | 27 | $1,647 | $61 |
| Acarbose | 13 | $1,477 | $114 |
| Baclofen | 18 | $1,392 | $77 |
| Hydrocortisone | 60 | $1,325 | $22 |
| Rosuvastatin | 25 | $1,068 | $43 |
| Fluticasone Propionate | 99 | $1,014 | $10 |
| Pantoprazole | 51 | $1,004 | $20 |
| Allopurinol | 42 | $964 | $23 |
| Hydrochlorothiazide | 131 | $942 | $7 |
| Simvastatin | 67 | $932 | $14 |
| Escitalopram | 36 | $929 | $26 |
| Gabapentin | 28 | $905 | $32 |
| Carvedilol | 37 | $885 | $24 |
| Rifampin | 13 | $882 | $68 |
| Pravastatin | 32 | $878 | $27 |
| Azelastine | 21 | $860 | $41 |
| Mirtazapine | 36 | $855 | $24 |
| Doxazosin Mesylate | 22 | $787 | $36 |
| Celecoxib | 12 | $774 | $64 |
| Olopatadine | 14 | $760 | $54 |
| Trazodone | 52 | $737 | $14 |
| Betamethasone Dipropionate | 11 | $652 | $59 |
| Finasteride | 33 | $624 | $19 |
| Glipizide | 54 | $618 | $11 |
| Clopidogrel | 20 | $612 | $31 |
| Omeprazole | 36 | $492 | $14 |
| Naproxen | 29 | $491 | $17 |
| Sertraline | 23 | $462 | $20 |
| Montelukast | 18 | $395 | $22 |
| Meclizine | 29 | $373 | $13 |
| Benazepril | 27 | $363 | $13 |
| Metoprolol | 44 | $360 | $8 |
| Glipizide Er | 14 | $348 | $25 |
| Triamcinolone Acetonide | 59 | $321 | $5 |
| Donepezil | 16 | $313 | $20 |
| Citalopram Hbr | 19 | $308 | $16 |
| Metformin Hcl Er | 21 | $258 | $12 |
| Hydralazine | 12 | $256 | $21 |
| Furosemide | 43 | $243 | $6 |
| Atenolol | 20 | $210 | $11 |
| Pioglitazone | 14 | $200 | $14 |
| Paxlovid (Eua) | 22 | $185 | $8 |
| Amoxicillin-Clavulanate Potass | 11 | $146 | $13 |
| Prednisone | 15 | $81 | $5 |
| Ibuprofen | 12 | $71 | $6 |
| Lovastatin | 12 | $59 | $5 |
2021: 70 drugs
| Januvia | 47 | $71,532 | $1,522 |
| Tradjenta | 23 | $33,592 | $1,461 |
| Xarelto | 11 | $17,300 | $1,573 |
| Lantus Solostar | 22 | $14,071 | $640 |
| Advair Diskus | 23 | $13,660 | $594 |
| Entecavir | 11 | $13,170 | $1,197 |
| Atorvastatin | 480 | $8,597 | $18 |
| Symbicort | 16 | $7,788 | $487 |
| Breo Ellipta | 15 | $5,962 | $397 |
| Onglyza | 12 | $5,870 | $489 |
| Colchicine | 24 | $5,472 | $228 |
| Flovent Hfa | 15 | $5,041 | $336 |
| Losartan | 268 | $4,462 | $17 |
| Diclofenac | 134 | $4,395 | $33 |
| Amlodipine Besylate | 394 | $3,963 | $10 |
| Albuterol Sulfate Hfa | 78 | $3,612 | $46 |
| Metoprolol | 125 | $3,473 | $28 |
| Ventolin Hfa | 34 | $2,720 | $80 |
| Famotidine | 126 | $2,444 | $19 |
| Alendronate | 191 | $2,054 | $11 |
| Nifedipine Er | 25 | $1,990 | $80 |
| Mirtazapine | 33 | $1,824 | $55 |
| Metformin | 195 | $1,775 | $9 |
| Acarbose | 13 | $1,608 | $124 |
| Lisinopril | 186 | $1,554 | $8 |
| Fluocinonide | 31 | $1,501 | $48 |
| Levothyroxine | 59 | $1,467 | $25 |
| Allopurinol | 47 | $1,286 | $27 |
| Tamsulosin | 64 | $1,215 | $19 |
| Olopatadine | 16 | $1,191 | $74 |
| Rosuvastatin | 18 | $1,128 | $63 |
| Fluticasone Propionate | 94 | $1,082 | $12 |
| Trazodone | 61 | $917 | $15 |
| Finasteride | 36 | $892 | $25 |
| Pantoprazole | 50 | $867 | $17 |
| Hydrochlorothiazide | 138 | $823 | $6 |
| Omeprazole | 47 | $816 | $17 |
| Simvastatin | 91 | $732 | $8 |
| Hydrocortisone | 39 | $719 | $18 |
| Escitalopram | 32 | $710 | $22 |
| Doxazosin Mesylate | 23 | $675 | $29 |
| Azelastine | 14 | $598 | $43 |
| Lidocaine | 25 | $595 | $24 |
| Gabapentin | 33 | $573 | $17 |
| Terazosin | 20 | $543 | $27 |
| Metoprolol | 76 | $478 | $6 |
| Pravastatin | 28 | $473 | $17 |
| Carvedilol | 24 | $429 | $18 |
| Glipizide | 55 | $426 | $8 |
| Glipizide Er | 14 | $414 | $30 |
| Meclizine | 30 | $386 | $13 |
| Naproxen | 44 | $381 | $9 |
| Donepezil | 22 | $374 | $17 |
| Triamcinolone Acetonide | 48 | $351 | $7 |
| Benazepril | 27 | $314 | $12 |
| Ibuprofen | 28 | $292 | $10 |
| Latanoprost | 13 | $270 | $21 |
| Furosemide | 35 | $266 | $8 |
| Sertraline | 20 | $242 | $12 |
| Clotrimazole | 13 | $233 | $18 |
| Clopidogrel | 17 | $210 | $12 |
| Hydroxyzine | 12 | $207 | $17 |
| Hydralazine | 13 | $206 | $16 |
| Atenolol | 18 | $172 | $10 |
| Pioglitazone | 11 | $151 | $14 |
| Warfarin | 16 | $134 | $8 |
| Montelukast | 13 | $107 | $8 |
| Lovastatin | 13 | $89 | $7 |
| Prednisone | 13 | $68 | $5 |
| Easy Touch Alcohol Prep Pads | 14 | $50 | $4 |
2020: 66 drugs
| Januvia | 38 | $56,138 | $1,477 |
| Tradjenta | 25 | $27,835 | $1,113 |
| Entecavir | 11 | $20,952 | $1,905 |
| Xarelto | 13 | $18,406 | $1,416 |
| Eliquis | 12 | $16,138 | $1,345 |
| Advair Diskus | 28 | $12,680 | $453 |
| Incruse Ellipta | 20 | $12,180 | $609 |
| Symbicort | 17 | $10,072 | $592 |
| Lantus Solostar | 14 | $9,478 | $677 |
| Breo Ellipta | 21 | $7,965 | $379 |
| Flovent Hfa | 18 | $5,612 | $312 |
| Atorvastatin | 407 | $4,818 | $12 |
| Diclofenac | 171 | $4,361 | $26 |
| Ventolin Hfa | 57 | $4,220 | $74 |
| Lantus | 13 | $3,910 | $301 |
| Albuterol Sulfate Hfa | 55 | $3,221 | $59 |
| Losartan | 246 | $3,097 | $13 |
| Metoprolol | 119 | $2,714 | $23 |
| Acarbose | 17 | $2,046 | $120 |
| Amlodipine Besylate | 368 | $1,814 | $5 |
| Levothyroxine | 63 | $1,577 | $25 |
| Travoprost | 13 | $1,461 | $112 |
| Metformin | 194 | $1,247 | $6 |
| Nifedipine Er | 19 | $1,245 | $66 |
| Alendronate | 141 | $1,225 | $9 |
| Famotidine | 91 | $1,172 | $13 |
| Rosuvastatin | 16 | $1,127 | $70 |
| Valsartan | 16 | $1,046 | $65 |
| Fluticasone Propionate | 83 | $939 | $11 |
| Lisinopril | 181 | $938 | $5 |
| Mirtazapine | 20 | $913 | $46 |
| Triamcinolone Acetonide | 60 | $897 | $15 |
| Allopurinol | 56 | $867 | $15 |
| Tamsulosin | 49 | $701 | $14 |
| Lidocaine | 15 | $681 | $45 |
| Doxazosin Mesylate | 21 | $629 | $30 |
| Finasteride | 34 | $608 | $18 |
| Simvastatin | 90 | $601 | $7 |
| Trazodone | 61 | $586 | $10 |
| Azelastine | 16 | $563 | $35 |
| Terazosin | 21 | $545 | $26 |
| Omeprazole | 61 | $537 | $9 |
| Glipizide | 59 | $509 | $9 |
| Hydrochlorothiazide | 107 | $507 | $5 |
| Hydrocortisone | 38 | $431 | $11 |
| Metoprolol | 74 | $402 | $5 |
| Gabapentin | 39 | $362 | $9 |
| Pravastatin | 16 | $332 | $21 |
| Baclofen | 11 | $319 | $29 |
| Clopidogrel | 30 | $313 | $10 |
| Hydroxyzine | 17 | $310 | $18 |
| Meclizine | 27 | $299 | $11 |
| Benazepril | 34 | $289 | $8 |
| Potassium Chloride | 11 | $264 | $24 |
| Pantoprazole | 27 | $261 | $10 |
| Escitalopram | 21 | $256 | $12 |
| Hydralazine | 18 | $242 | $13 |
| Clotrimazole | 12 | $223 | $19 |
| Warfarin | 16 | $194 | $12 |
| Carvedilol | 18 | $166 | $9 |
| Furosemide | 36 | $159 | $4 |
| Naproxen | 29 | $153 | $5 |
| Ibuprofen | 20 | $124 | $6 |
| Lovastatin | 12 | $100 | $8 |
| Metformin Hcl Er | 11 | $65 | $6 |
| Atenolol | 17 | $63 | $4 |
2019: 32 drugs
| Januvia | 11 | $15,324 | $1,393 |
| Ventolin Hfa | 39 | $2,476 | $63 |
| Atorvastatin | 120 | $1,631 | $14 |
| Diclofenac | 42 | $1,246 | $30 |
| Voltaren | 16 | $879 | $55 |
| Metoprolol | 27 | $842 | $31 |
| Losartan | 55 | $788 | $14 |
| Fluticasone Propionate | 46 | $751 | $16 |
| Mirtazapine | 11 | $673 | $61 |
| Amlodipine Besylate | 75 | $571 | $8 |
| Omeprazole | 38 | $535 | $14 |
| Levothyroxine | 17 | $477 | $28 |
| Lisinopril | 64 | $464 | $7 |
| Ranitidine | 18 | $430 | $24 |
| Triamcinolone Acetonide | 25 | $400 | $16 |
| Alendronate | 35 | $399 | $11 |
| Allopurinol | 17 | $345 | $20 |
| Metformin | 59 | $324 | $5 |
| Gabapentin | 19 | $322 | $17 |
| Trazodone | 24 | $280 | $12 |
| Simvastatin | 21 | $255 | $12 |
| Tamsulosin | 15 | $226 | $15 |
| Prednisone | 26 | $225 | $9 |
| Hydrochlorothiazide | 34 | $214 | $6 |
| Naproxen | 29 | $214 | $7 |
| Hydrocortisone | 21 | $174 | $8 |
| Clopidogrel | 17 | $166 | $10 |
| Escitalopram | 16 | $143 | $9 |
| Glipizide | 22 | $141 | $6 |
| Ibuprofen | 19 | $140 | $7 |
| Midodrine | 11 | $98 | $9 |
| Furosemide | 12 | $47 | $4 |
2018: 16 drugs
| Ventolin Hfa | 11 | $783 | $71 |
| Gabapentin | 29 | $553 | $19 |
| Levothyroxine | 20 | $283 | $14 |
| Fluticasone Propionate | 20 | $262 | $13 |
| Paroxetine | 20 | $249 | $12 |
| Polyethylene Glycol 3350 | 15 | $220 | $15 |
| Ondansetron Odt | 12 | $208 | $17 |
| Omeprazole | 22 | $205 | $9 |
| Mirtazapine | 17 | $156 | $9 |
| Losartan | 16 | $154 | $10 |
| Atenolol | 14 | $153 | $11 |
| Atorvastatin | 12 | $142 | $12 |
| Pantoprazole | 24 | $137 | $6 |
| Simvastatin | 19 | $82 | $4 |
| Lisinopril | 28 | $56 | $2 |
| Amlodipine Besylate | 22 | $52 | $2 |
2017: 33 drugs
| Flovent Hfa | 13 | $4,028 | $310 |
| Oxycodone-Acetaminophen | 27 | $1,645 | $61 |
| Proair Hfa | 21 | $1,229 | $59 |
| Ventolin Hfa | 12 | $707 | $59 |
| Oxycodone | 24 | $660 | $27 |
| Levothyroxine | 27 | $525 | $19 |
| Morphine Sulfate Er | 13 | $508 | $39 |
| Gabapentin | 28 | $421 | $15 |
| Polyethylene Glycol 3350 | 25 | $416 | $17 |
| Metoprolol | 13 | $355 | $27 |
| Fluticasone Propionate | 21 | $245 | $12 |
| Omeprazole | 35 | $242 | $7 |
| Naproxen | 13 | $191 | $15 |
| Lisinopril | 39 | $185 | $5 |
| Atorvastatin | 15 | $178 | $12 |
| Paroxetine | 13 | $176 | $14 |
| Ibuprofen | 19 | $167 | $9 |
| Clonazepam | 23 | $110 | $5 |
| Simvastatin | 18 | $89 | $5 |
| Allopurinol | 12 | $88 | $7 |
| Montelukast | 11 | $85 | $8 |
| Amlodipine Besylate | 27 | $71 | $3 |
| Pantoprazole | 12 | $64 | $5 |
| Cyclobenzaprine | 11 | $59 | $5 |
| Ranitidine | 11 | $55 | $5 |
| Hydrochlorothiazide | 22 | $53 | $2 |
| Furosemide | 16 | $51 | $3 |
| Dicyclomine | 11 | $51 | $5 |
| Citalopram Hbr | 13 | $48 | $4 |
| Sertraline | 13 | $46 | $4 |
| Losartan | 12 | $40 | $3 |
| Trazodone | 11 | $31 | $3 |
| Diazepam | 12 | $28 | $2 |
2016: 5 drugs
| Oxycodone | 13 | $316 | $24 |
| Amlodipine Besylate | 25 | $80 | $3 |
| Hydrochlorothiazide | 13 | $63 | $5 |
| Lisinopril | 20 | $39 | $2 |
| Sertraline | 11 | $27 | $2 |
Money from drug and device companies
$21 in 2025
A payment is not proof that care is biased.
| CooperSurgical | Paragard T 380a | $21 | 1 payment
|
See the published payment
| CooperSurgical | Meals · 2025-07-11 | Paragard T 380a | $21 |
Professional record
- NPI
- 1902292030
- Licence
- CA A156687California A156687: Current · expires 2027-09-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 835 Webster Street,, Oakland, CA, 94607
- NPI first listed
- 2015-04-15
- NPI last updated
- 2019-02-14
This is when the NPI record was last certified, not a medical board exam.